IBC0966 / SunHo BioPharma - LARVOL DELTA

Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors (clinicaltrials.gov) - P1/2 | N=228 | Recruiting | Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Breast Cancer • Head and Neck Cancer • Hematological Malignancies • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Peripheral T-cell Lymphoma • Solid Tumor • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • ER • HER-2 • PD-L1 • PGR

Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors (clinicaltrials.gov) - P1/2; N=228; Not yet recruiting; Sponsor: SUNHO（China）BioPharmaceutical CO., Ltd.

New P1/2 trial • Breast Cancer • Head and Neck Cancer • Hematological Malignancies • HER2 Breast Cancer • Hormone Receptor Breast Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Peripheral T-cell Lymphoma • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • ER • HER-2 • PD-L1 • PGR